RxDoctor Payments Data

Alyssa Coogan

Nurse Practitioner · Dartmouth, MANPI 1801302765

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.5% of the total across 304 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,523, 9.9 times the $255 reported in 2021. Among nurse practitioner clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,529in general payments, 2019–2025

Across 304 payments — averaging $21.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • E.r. Squibb & Sons, L.L.C.$913
  • Johnson & Johnson$777
  • LEO Pharma Inc.$663
  • Sanofi$491
  • Regeneron Healthcare Solutions, Inc.$444
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$6,10293%
  • Education$4277%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,529 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.

See all nurse practitioner providers in Massachusetts

Medicare billing

Part B allowed, 2024
$106,889
Medicare patients
409
Services billed
1,813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab30$113,390
Fluocinonide116$4,012
Ketoconazole189$3,172
Clindamycin Phosphate59$2,518
Tacrolimus11$2,286
Tretinoin12$1,349
Clobetasol Propionate18$978
Ammonium Lactate57$969
Metronidazole26$921
Doxycycline Hyclate46$848
Triamcinolone Acetonide64$805
Mometasone Furoate28$434
Betamethasone Dipropionate13$400
Hydrocortisone79$349
Mupirocin44$327

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Dartmouth

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →